Tacrolimus Extended Release Oral Tablet [Envarsus]

DRUG4 trials

Sponsors

Lorenzo Gallon, University of Colorado, Denver, Simon Tremblay, PharmD, PhD, Vanderbilt University Medical Center

Conditions

End Stage Renal DiseaseImmunosuppressionKidney Transplant RejectionKidney TransplantationLung Transplant; ComplicationsRejection of Renal Transplant

Early Phase 1

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

TerminatedNCT03380936

University of Colorado, DenverKidney Transplant Rejection

Start: 2018-01-17End: 2019-10-16Updated: 2020-10-27

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

RecruitingNCT04469842

Vanderbilt University Medical CenterLung Transplant; Complications

Start: 2023-12-01End: 2027-12-31Target: 48Updated: 2026-05-15

Phase 3

Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

CompletedNCT03289650

Lorenzo GallonEnd Stage Renal Disease, Rejection of Renal Transplant

Start: 2017-09-05End: 2021-02-23Updated: 2023-04-10

Phase 4

Veloxis de Novo Kidney Transplant ECSWD

Simon Tremblay, PharmD, PhDImmunosuppression, Kidney Transplantation

Start: 2019-06-21End: 2022-06-30Target: 60Updated: 2020-05-13